Life Sciences Future

Life Sciences Future – It’s Here!

September 27 – 28, 2023

Life Sciences Future, the largest annual gathering of the life sciences community on the east coast, is the conference for all stakeholders of the life sciences ecosystem – biopharma, med tech, academic research, hospitality, legal, financial, real estate communities and more. Conference features include partnering, plenary sessions of broad interest, and focused sessions on timely topics and speakers.

This conference will be the ultimate partnering event on the east coast – with opportunities for one-on-one partnering with the biggest names in the industry.



Access one-on-one partnering with hundreds of the biggest names in the industry.

Panel Discussions

Hear from experts from the life sciences community about the hottest topics in the industry.

Reverse Pitch Presentations

Hear from top life sciences and investment organizations on what they are looking for to fill their portfolio.


Organizations will showcase their company’s services and network with other attendees.

Poster Presentations

Attendees from academic research institutions and spin-outs will present their cutting-edge science to a panel of reviewers.

Company Presentations

Organizations will present their pitch deck for feedback and partnership opportunities.



Olympic Gold Medalist
Cancer Survivor & Activist

The most recognized male figure skating star in the world, Scott Hamilton has won 70 titles, awards and honors including an Emmy Award nomination, induction into the United States Olympic Hall of Fame and a privileged member of the World Figure Skating Hall of Fame.

After losing his mother to cancer, then becoming a survivor himself, Scott turned activist, launching the Scott Hamilton CARES Foundation (Cancer Alliance for Research, Education and Survivorship). He founded several education and survivorship programs including and the fourth Angel Mentoring Program.


Professor, Medicine and Pediatrics
Director, Gene Therapy Program

James M. Wilson, MD, PhD, is a Professor in the Perelman School of Medicine at the University of Pennsylvania where he has led an effort to develop the field of gene therapy. His research career spanning over 40 years has focused on rare diseases and ways to treat them by gene therapy.

The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy.

Krish Krishnan

Chairman & CEO
Krystal Biotech

Krish Krishnan is the Chairman and CEO of Krystal Biotech, a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. In May 2023, the FDA approved VYJUVEK for the treatment of patients six months of age or older with dystrophic epidermolysis bullosa (DEB).

Throughout his career, Krish was specifically involved in two successful IPOs, the approval of the blockbuster drug Vyvanse (for ADHD in 2007) and the sale of New River Pharmaceuticals to Shire Pharmaceuticals.


Conference Co-Chairs:

Tara Muzsi, Vice President, Immunology Sales & Marketing, Gastroenterology, Janssen

John Witkowski, President, DSM Biomedical

Mike Bowman, President & CEO, Valley Forge Tourism & Convention Board


Committees & Chairs:

Academic Outreach – Identify issues and opportunities faced by research institutions, early to mid-stage companies, and business development teams forging early-stage relationships. Suggest speakers that should be considered, either from your own research institutions or individuals you have heard at other conferences.
  • Kenny Simansky, Drexel University
  • John Swartley, Penn Center for Innovation, University of Pennsylvania
  • Erika Swift, Center for Medical Innovation, Penn State College of Medicine


Advocacy – Assist with identifying topics and speakers who would share pertinent information about policy from state and federal government.
  • Dom Argento, State Government Affairs & Policy, Merck
  • Amy Redl, Federal Government Relations, Sanofi


Company Presentations – Help identify new and emerging companies to present during the Company Presentation portion of LSF. Presenting companies will be selected by a review committee.
  • John Pennett, EisnerAmper
  • Doreen Trujilo, Saul Ewing


Hospitality, Meetings & Conventions – What effect does the life sciences community have in the hospitality, meetings, and conventions industry? Help identify key topics to cover during the conference that highlight the life sciences community and its intersections with the hospitality industry.
  • Bonnie Grant, Convention & Visitors Bureau
  • Lisa Karl, Valley Forge Tourism & Convention Board


Program/Agenda – Assist with identifying conference topics and conference speakers. LSPA will facilitate outreach to speakers and will keep the committee updated on the progress.
  • Maureen Mulvihill, Actuated Medical
  • Neal Walker, Aclaris Therapeutics


Promotional Outreach – Assist with getting the word out! Strategizing ideas on communication tactics that will drive interest in LSF.
  • Ed Seiders, 20/20 Visual Media
  • Kathena Siegel, DSM Biomedical


Real Estate – It’s the hottest time in life sciences real estate in decades. Tell us why… and help tell the conference why!
  • Joe Colletti, JLL
  • John Grady, Wexford Science + Technology


Talent – What do leaders need to know to be up-to-date on the newest trends in talent recruitment, development and retention? What about DE&I initiatives and other employee priorities in today’s fast-changing climate.
  • Bert Bruce, Pfizer
  • Marcia O’Connor, The O’Connor Group